Short answer:
No—there isn’t a generic version of Saxenda that you can buy off‑the‑shelf. The drug is still sold only under its brand name (and as its diabetes counterpart, Victoza, which uses the same active ingredient).
---
Why Saxenda doesn’t have a generic yet
| What’s in Saxenda? | What’s in Victoza? | Why the difference matters |
|-------------------|--------------------|----------------------------|
| Liraglutide 3 mg/mL (injected once daily for weight management) | Liraglutide 0.6 mg/mL (injected once daily for type 2 diabetes) | The dose and indication are different. The FDA requires separate approval for each product even if the active ingredient is the same. |
| Brand name: Saxenda (weight‑loss) | Brand name: Victoza (diabetes) | The manufacturer (Novo Nordisk) holds the patents and regulatory approvals for each formulation. |
- Patent status: The patents that protect Saxenda’s formulation and dosing are still in force in most markets. Generics can only appear once these patents expire or if a competitor successfully files a generic application and receives approval.
- Regulatory pathway: Even if a generic version of liraglutide existed, it would still need to demonstrate bioequivalence to the Saxenda formulation specifically, not just Victoza.
---
What you can find
| Generic / Alternative | Availability | Notes |
|-----------------------|--------------|-------|
| Victoza (generic liraglutide) | Available in many countries | Same drug, lower dose for diabetes. It can’t be used for weight management without a prescription and specific dosing. |
| Other GLP‑1 agonists (e.g., semaglutide – Wegovy for obesity; dulaglutide – Trulicity for diabetes) | Generics of some are in development but not yet marketed | These are different molecules, not generic versions of Saxenda. |
---
Bottom line for patients
- If you’re prescribed Saxenda for weight loss, you’ll need to continue using the brand‑name product until a generic version becomes approved and available in your country.
- Check with your pharmacist or prescriber: They can confirm if a generic version has entered the market in your jurisdiction, or whether any other approved weight‑loss GLP‑1 option might fit your needs.
---
Disclaimer – The information above reflects the status up to July 2026. Regulatory approvals can change, so always verify with a local pharmacy or the official drug‑approval authority (e.g., FDA in the U.S., EMA in the EU).